METASTATIC UVEAL MELANOMA
Clinical trials for METASTATIC UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver chemo attack shows promise for rare eye cancer spread
Disease control OngoingThis study tests a treatment for uveal melanoma that has spread to the liver. Doctors inject chemotherapy (BCNU) mixed with an oily dye directly into the liver's blood supply, then block the artery with a sponge-like material. The goal is to shrink or control liver tumors. The st…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 08:24 UTC
-
New drug cocktail targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests several new drug combinations in people with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the drugs can shrink tumors. About 352 adults with specific cancer types will participate…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:23 UTC
-
New drug cocktail aims to shrink rare eye cancer tumors
Disease control OngoingThis study tests whether combining two drugs, binimetinib and belinostat, can shrink or stop the growth of tumors in people with metastatic uveal melanoma, a rare eye cancer that has spread. About 7 adults with advanced disease are taking part. The goal is to see if the treatment…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New drug trial targets rare eye cancer that spreads
Disease control OngoingThis study tests a drug called vorinostat in 40 people with uveal melanoma that has spread to other parts of the body. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it can shrink tumors and help people live longer.
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo shows promise for rare eye cancer, but not a cure
Disease control OngoingThis study tests two drugs, pembrolizumab and lenvatinib, in people with a rare eye cancer that has spread (metastatic uveal melanoma). The goal is to see if the combination can slow or stop tumor growth. About 51 adults are taking part, and they will be monitored with scans ever…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug combo shows promise for rare eye cancer that spreads
Disease control OngoingThis study tests a new combination of two drugs (IDE196 and crizotinib) against standard treatments for people with a rare eye cancer (uveal melanoma) that has spread to other parts of the body. The trial includes 420 adults whose cancer cells lack a specific marker (HLA-A2 negat…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2, PHASE3 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC